Medical cannabis: thinking out of the box of the healthcare system

Fortin Davide () and Sophie Massin

Post-Print from HAL

Abstract: France is about to experiment with legal access to medical cannabis. In this short contribution, we propose an analysis of this regulation choice in light of the intrinsic characteristics of medical cannabis and the lessons learned from other countries. More precisely, we argue that scientific evidence for the efficacy of cannabis is limited, which favors restrictive regulation schemes, similar to those found in other European countries. However, since there are strong technical and economic barriers to demonstrating the efficacy of medical cannabis, more accommodative regulatory frameworks such as those found in North America, have advantages, but these are also at risk of excessive or diverted use. In order to keep the best of both systems, it might be possible to design innovative regulatory frameworks based on a dual-distribution system for medical cannabis. Cannabis Social Clubs, for example, could serve as a distribution structure complementary to the conventional healthcare system.

Date: 2020-02
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Published in Journal de gestion et d'économie de la santé, 2020, 2, pp.110-118

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-03131289

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().